Cargando…

Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?

AIMS: Heart failure (HF) management is complicated by difficulties in clinical assessment. Biomarkers may help guide HF management, but the correspondence between clinical evaluation and biomarker serum levels has hardly been studied. We investigated the correlation between biomarkers and clinical s...

Descripción completa

Detalles Bibliográficos
Autores principales: Peeters, J. M. P. W. U., Sanders-van Wijk, S., Bektas, S., Knackstedt, C., Rickenbacher, P., Nietlispach, F., Handschin, R., Maeder, M. T., Muzzarelli, S. F., Pfisterer, M. E., Brunner-La Rocca, H. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931853/
https://www.ncbi.nlm.nih.gov/pubmed/24338787
http://dx.doi.org/10.1007/s12471-013-0503-y
_version_ 1782304725481291776
author Peeters, J. M. P. W. U.
Sanders-van Wijk, S.
Bektas, S.
Knackstedt, C.
Rickenbacher, P.
Nietlispach, F.
Handschin, R.
Maeder, M. T.
Muzzarelli, S. F.
Pfisterer, M. E.
Brunner-La Rocca, H. P.
author_facet Peeters, J. M. P. W. U.
Sanders-van Wijk, S.
Bektas, S.
Knackstedt, C.
Rickenbacher, P.
Nietlispach, F.
Handschin, R.
Maeder, M. T.
Muzzarelli, S. F.
Pfisterer, M. E.
Brunner-La Rocca, H. P.
author_sort Peeters, J. M. P. W. U.
collection PubMed
description AIMS: Heart failure (HF) management is complicated by difficulties in clinical assessment. Biomarkers may help guide HF management, but the correspondence between clinical evaluation and biomarker serum levels has hardly been studied. We investigated the correlation between biomarkers and clinical signs and symptoms, the influence of patient characteristics and comorbidities on New York Heart Association (NYHA) classification and the effect of using biomarkers on clinical evaluation. METHODS AND RESULTS: This post-hoc analysis comprised 622 patients (77 ± 8 years, 76 % NYHA class ≥3, 80 % LVEF ≤45 %) participating in TIME-CHF, randomising patients to either NT-proBNP-guided or symptom-guided therapy. Biomarker measurements and clinical evaluation were performed at baseline and after 1, 3, 6, 12 and 18 months. NT-proBNP, GDF-15, hs-TnT and to a lesser extent hs-CRP and cystatin-C were weakly correlated to NYHA, oedema, jugular vein distension and orthopnoea (ρ-range: 0.12–0.33; p < 0.01). NT-proBNP correlated more strongly to NYHA class in the NT-proBNP-guided group compared with the symptom-guided group. NYHA class was significantly influenced by age, body mass index, anaemia, and the presence of two or more comorbidities. CONCLUSION: In HF, biomarkers correlate only weakly with clinical signs and symptoms. NYHA classification is influenced by several comorbidities and patient characteristics. Clinical judgement seems to be influenced by a clinician’s awareness of NT-proBNP concentrations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12471-013-0503-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3931853
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Bohn Stafleu van Loghum
record_format MEDLINE/PubMed
spelling pubmed-39318532014-02-28 Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment? Peeters, J. M. P. W. U. Sanders-van Wijk, S. Bektas, S. Knackstedt, C. Rickenbacher, P. Nietlispach, F. Handschin, R. Maeder, M. T. Muzzarelli, S. F. Pfisterer, M. E. Brunner-La Rocca, H. P. Neth Heart J Original Article AIMS: Heart failure (HF) management is complicated by difficulties in clinical assessment. Biomarkers may help guide HF management, but the correspondence between clinical evaluation and biomarker serum levels has hardly been studied. We investigated the correlation between biomarkers and clinical signs and symptoms, the influence of patient characteristics and comorbidities on New York Heart Association (NYHA) classification and the effect of using biomarkers on clinical evaluation. METHODS AND RESULTS: This post-hoc analysis comprised 622 patients (77 ± 8 years, 76 % NYHA class ≥3, 80 % LVEF ≤45 %) participating in TIME-CHF, randomising patients to either NT-proBNP-guided or symptom-guided therapy. Biomarker measurements and clinical evaluation were performed at baseline and after 1, 3, 6, 12 and 18 months. NT-proBNP, GDF-15, hs-TnT and to a lesser extent hs-CRP and cystatin-C were weakly correlated to NYHA, oedema, jugular vein distension and orthopnoea (ρ-range: 0.12–0.33; p < 0.01). NT-proBNP correlated more strongly to NYHA class in the NT-proBNP-guided group compared with the symptom-guided group. NYHA class was significantly influenced by age, body mass index, anaemia, and the presence of two or more comorbidities. CONCLUSION: In HF, biomarkers correlate only weakly with clinical signs and symptoms. NYHA classification is influenced by several comorbidities and patient characteristics. Clinical judgement seems to be influenced by a clinician’s awareness of NT-proBNP concentrations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12471-013-0503-y) contains supplementary material, which is available to authorized users. Bohn Stafleu van Loghum 2013-12-14 2014-03 /pmc/articles/PMC3931853/ /pubmed/24338787 http://dx.doi.org/10.1007/s12471-013-0503-y Text en © The Author(s) 2013 https://creativecommons.org/licenses/by/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Article
Peeters, J. M. P. W. U.
Sanders-van Wijk, S.
Bektas, S.
Knackstedt, C.
Rickenbacher, P.
Nietlispach, F.
Handschin, R.
Maeder, M. T.
Muzzarelli, S. F.
Pfisterer, M. E.
Brunner-La Rocca, H. P.
Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?
title Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?
title_full Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?
title_fullStr Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?
title_full_unstemmed Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?
title_short Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?
title_sort biomarkers in outpatient heart failure management; are they correlated to and do they influence clinical judgment?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931853/
https://www.ncbi.nlm.nih.gov/pubmed/24338787
http://dx.doi.org/10.1007/s12471-013-0503-y
work_keys_str_mv AT peetersjmpwu biomarkersinoutpatientheartfailuremanagementaretheycorrelatedtoanddotheyinfluenceclinicaljudgment
AT sandersvanwijks biomarkersinoutpatientheartfailuremanagementaretheycorrelatedtoanddotheyinfluenceclinicaljudgment
AT bektass biomarkersinoutpatientheartfailuremanagementaretheycorrelatedtoanddotheyinfluenceclinicaljudgment
AT knackstedtc biomarkersinoutpatientheartfailuremanagementaretheycorrelatedtoanddotheyinfluenceclinicaljudgment
AT rickenbacherp biomarkersinoutpatientheartfailuremanagementaretheycorrelatedtoanddotheyinfluenceclinicaljudgment
AT nietlispachf biomarkersinoutpatientheartfailuremanagementaretheycorrelatedtoanddotheyinfluenceclinicaljudgment
AT handschinr biomarkersinoutpatientheartfailuremanagementaretheycorrelatedtoanddotheyinfluenceclinicaljudgment
AT maedermt biomarkersinoutpatientheartfailuremanagementaretheycorrelatedtoanddotheyinfluenceclinicaljudgment
AT muzzarellisf biomarkersinoutpatientheartfailuremanagementaretheycorrelatedtoanddotheyinfluenceclinicaljudgment
AT pfistererme biomarkersinoutpatientheartfailuremanagementaretheycorrelatedtoanddotheyinfluenceclinicaljudgment
AT brunnerlaroccahp biomarkersinoutpatientheartfailuremanagementaretheycorrelatedtoanddotheyinfluenceclinicaljudgment